ENTOS PHARMACEUTICALS INC.

City:

Edmonton

Country:

Canada

Published Applications:

Last publication date:

2023-06-22

Patent Grants:

Last grant date:

2025-10-28

Top Inventors for applications by ENTOS PHARMACEUTICALS INC.

These are the the leading inventors for applications assigned to ENTOS PHARMACEUTICALS INC.:

Roy Duncan 4 Mineville, Canada
John Lewis 3 London, Canada
Rae-Lynn Nesbitt 3 Port Stanley, Canada
Eileen Kathryn Clancy 3 San Francisco,, CA United States

Roberto Justo De Antueno 3 Halifax, Canada
Lian Willetts 2 Edmonton, Canada
John Lewis 2 Edmonton, Canada
Konstantin Stoletov 2 Edmonton, Canada

Roy Duncan 1 Mineville, CA United States
Chungen Pan 1 Guangzhou, China

Recent patent applications by ENTOS PHARMACEUTICALS INC.

ENTOS PHARMACEUTICALS INC. based in Edmonton, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-06-22 ✅ Patent 12,454,557 granted on 2025-10-28

US20230192783A1

Chemistry; metallurgy

RECOMBINANT POLYPEPTIDES FOR MEMBRANE FUSION AND USES THEREOF

#2 | 2022-04-14 ✅ Patent 12,421,514 granted on 2025-09-23

US20220112498A1

Chemistry; metallurgy

METHODS FOR DIAGNOSING AND TREATING METASTATIC CANCER

#3 | 2020-04-23 ✅ Patent 12,378,289 granted on 2025-08-05

US20200123204A1

Chemistry; metallurgy

RECOMBINANT ONCOLYTIC VIRUSES FOR TREATMENT OF METASTATIC CANCERS

#4 | 2019-12-05 ✅ Patent 11,459,362 granted on 2022-10-04

US20190367566A1

Chemistry; metallurgy

Recombinant polypepties for membrane fusion and uses thereof

#5 | 2019-06-13 ✅ Patent 11,236,331 granted on 2022-02-01

US20190177727A1

Chemistry; metallurgy

Methods for diagnosing and treating metastatic cancer

#6 | 2014-10-23 ✅ Patent 10,227,386 granted on 2019-03-12

US20140314831A1

Chemistry; metallurgy

Recombinant polypeptides for membrane fusion and uses thereof

Also check out Entos Pharmaceuticals Inc.'s (Edmonton, Canada) applicant profile with 8 patent applications submitted.

AssigneeID:

371380 ⎘